This inventor holds 22 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Reverse Proteomics Research Institute, Nishizaki Bioinformation Research Institute. Active years: 1989-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takarazuka, JP (1992 - 2001)
- Osaka, JP (2008)
- Tsukuba, JP (2001 - 2011)
- Ibaraki, JP (2010 - 2011)
- Kisarazu, JP (2014)
- Toyonaka, JP (1989 - 2018)
Company Filing History:
8 out of 940 
7 out of 13 
4 out of 8 
Years Active: 1989-2018
Areas of Expertise:
Title: Akito Tanaka: A Pioneer in Elastin and Alzheimer’s Research
Introduction: Akito Tanaka, an innovative inventor based in Tsukuba, Japan, has made significant contributions to the fields of biotechnology and pharmaceuticals. With 22 patents to his name, Mr. Tanaka's work primarily focuses on agents that promote elastin synthesis and regeneration, along with therapeutic solutions for neurodegenerative disorders.
Latest Patents: Among Tanaka's latest patents is an elastin synthesis/regeneration promoting agent known as 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA). This compound is designed to promote the synthesis and regeneration of elastin, and it is particularly notable for its effects in preventing wrinkles and serving as an anti-aging drug. Another significant patent covers an inhibitor of protein phosphorylation. Also based on 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid, this invention features a protein tyrosine phosphatase 1B (PTP1B) inhibitory action, which has therapeutic implications for Alzheimer-type dementia and may also serve as an antidepressant and anti-aging drug.
Career Highlights: Akito Tanaka has established a reputable career through his associations with notable companies, including Fujisawa Pharmaceutical Company Ltd. and Reverse Proteomics Research Institute Co., Ltd. His experience in these organizations has enriched his understanding and expertise in the development of innovative pharmaceutical agents.
Collaborations: Throughout his career, Tanaka has collaborated with esteemed colleagues such as Tomoyuki Nishizaki and Akira Yamazaki. These partnerships have allowed for the exchange of ideas and advancements in research, further enhancing the impact of his inventions.
Conclusion: Akito Tanaka stands out as a significant figure in the realm of biotechnology, with a focus on aging and neurodegenerative diseases. His inventions not only illustrate his innovative spirit but also hold the potential to create meaningful solutions in the fields of dermatology and neurology. As he continues to advance his research, the implications of his work will undoubtedly benefit many in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile